{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:06:20Z","timestamp":1794632780325,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009474","name":"Dr Ram Manohar Lohia Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["NOV-2017-343185"],"award-info":[{"award-number":["NOV-2017-343185"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cancergen.2022.09.006","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T01:43:25Z","timestamp":1663551805000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy"],"prefix":"10.1016","volume":"268-269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7374-0283","authenticated-orcid":false,"given":"Adil","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5864-8841","authenticated-orcid":false,"given":"Rahat","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avnish","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhup","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Haris","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuzhat","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cancergen.2022.09.006_bib0001","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/WNL.48.5.1336","article-title":"Chemotherapy response criteria in malignant glioma","volume":"48","author":"Grant","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cancergen.2022.09.006_bib0002","first-page":"149","article-title":"Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods","volume":"6","author":"Ahmed","year":"2014","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.cancergen.2022.09.006_bib0003","first-page":"1","article-title":"Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma","volume":"3","author":"Bagley","year":"2021","journal-title":"Neuro-Oncol Adv"},{"issue":"June","key":"10.1016\/j.cancergen.2022.09.006_bib0004","first-page":"1","article-title":"Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care","volume":"1","author":"Rennert","year":"2016","journal-title":"Npj Genomic Med"},{"issue":"3","key":"10.1016\/j.cancergen.2022.09.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-018-0820-z","article-title":"Liquid biopsy in primary brain tumors: looking for stardust!","volume":"18","author":"Fontanilles","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"10.1016\/j.cancergen.2022.09.006_bib0006","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/14737159.2020.1724094","article-title":"A profile on cobas\u00ae EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer","volume":"20","author":"Torres","year":"2020","journal-title":"Expert Rev Mol Diagn [Internet]"},{"issue":"3","key":"10.1016\/j.cancergen.2022.09.006_bib0007","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/neuonc\/nov289","article-title":"Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors","volume":"18","author":"Nikiforova","year":"2016","journal-title":"Neuro-Oncol"},{"issue":"9","key":"10.1016\/j.cancergen.2022.09.006_bib0008","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.5858\/arpa.2014-0588-CP","article-title":"Template for reporting results of biomarker testing of specimens from patients with tumors of the central nervous system","volume":"139","author":"Brat","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"JAN","key":"10.1016\/j.cancergen.2022.09.006_bib0009","first-page":"1","article-title":"Genetics and epigenetics of glioblastoma: applications and overall incidence of IDH1 mutation","volume":"6","author":"Liu","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.cancergen.2022.09.006_bib0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fncel.2014.00418","article-title":"Gliomas and the vascular fragility of the blood brain barrier","volume":"8","author":"Dubois","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"7655","key":"10.1016\/j.cancergen.2022.09.006_bib0011","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cancergen.2022.09.006_bib0012","first-page":"179","article-title":"Retrospective analysis of molecular and immunohistochemical characterization of 381 primary brain tumors","volume":"76","author":"Ballester","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"10.1016\/j.cancergen.2022.09.006_bib0013","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1158\/1078-0432.CCR-17-3800","article-title":"Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid","volume":"24","author":"Mart\u00ednez-Ricarte","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.cancergen.2022.09.006_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-017-1191-5","article-title":"CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA","volume":"18","author":"Kang","year":"2017","journal-title":"Genome Biol"},{"issue":"33","key":"10.1016\/j.cancergen.2022.09.006_bib0015","doi-asserted-by":"crossref","first-page":"e21196","DOI":"10.1097\/MD.0000000000021196","article-title":"Diagnostic value of circulating tumor DNA in molecular characterization of glioma: a meta-analysis","volume":"99","author":"Kang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"16","key":"10.1016\/j.cancergen.2022.09.006_bib0016","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.0b013e31826e9b0a","article-title":"Detection of IDH1 mutation in the plasma of patients with glioma","volume":"79","author":"Boisselier","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.cancergen.2022.09.006_bib0017","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/neuonc\/nop041","article-title":"Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades","volume":"12","author":"Lavon","year":"2010","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.cancergen.2022.09.006_bib0018","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"10","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.cancergen.2022.09.006_bib0019","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2022.09.006_bib0020","doi-asserted-by":"crossref","first-page":"V1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.cancergen.2022.09.006_bib0021","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat Commun [Internet]"},{"issue":"31","key":"10.1016\/j.cancergen.2022.09.006_bib0022","doi-asserted-by":"crossref","first-page":"9704","DOI":"10.1073\/pnas.1511694112","article-title":"Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci [Internet]"},{"issue":"2","key":"10.1016\/j.cancergen.2022.09.006_bib0023","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1078-0432.CCR-19-2533","article-title":"Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma: a pilot prospective study","volume":"26","author":"Bagley","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.cancergen.2022.09.006_bib0024","first-page":"1","article-title":"Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma","volume":"2","author":"Nabavizadeh","year":"2020","journal-title":"Neuro-Oncol Adv"},{"issue":"43","key":"10.1016\/j.cancergen.2022.09.006_bib0025","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.18632\/oncotarget.27030","article-title":"Cell-free DNA in newly diagnosed patients with glioblastoma \u2013 a clinical prospective feasibility study","volume":"10","author":"N\u00f8r\u00f8xe","year":"2019","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cancergen.2022.09.006_bib0026","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13311-016-0507-6","article-title":"Modified criteria for radiographic response assessment in glioblastoma clinical trials","volume":"14","author":"Ellingson","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"13","key":"10.1016\/j.cancergen.2022.09.006_bib0027","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","article-title":"Analysis of circulating tumor DNA to monitor metastatic breast cancer","volume":"368","author":"Dawson","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cancergen.2022.09.006_bib0028","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/IJPM.IJPM_28_20","article-title":"Circulating free DNA as a marker of response to chemoradiation in locally advanced head and neck squamous cell carcinoma","volume":"63","author":"Verma","year":"2020","journal-title":"Indian J Pathol Microbiol"},{"issue":"7447","key":"10.1016\/j.cancergen.2022.09.006_bib0029","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cancergen.2022.09.006_bib0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.molonc.2014.12.003","article-title":"Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types","volume":"9","author":"Lebofsky","year":"2015","journal-title":"Mol Oncol [Internet]"},{"issue":"43","key":"10.1016\/j.cancergen.2022.09.006_bib0031","doi-asserted-by":"crossref","first-page":"71013","DOI":"10.18632\/oncotarget.11717","article-title":"El-Khoury V. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer","volume":"7","author":"Bennett","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cancergen.2022.09.006_bib0032","first-page":"1","article-title":"Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma","volume":"8","author":"Fontanilles","year":"2020","journal-title":"Acta Neuropathol Commun [Internet]"},{"issue":"2","key":"10.1016\/j.cancergen.2022.09.006_bib0033","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1078-0432.CCR-19-2533","article-title":"Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma: a pilot prospective study","volume":"26","author":"Bagley","year":"2020","journal-title":"Clin Cancer Res [Internet]"},{"issue":"2","key":"10.1016\/j.cancergen.2022.09.006_bib0034","article-title":"Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors","volume":"8","author":"Piccioni","year":"2019","journal-title":"CNS Oncol [Internet]"},{"key":"10.1016\/j.cancergen.2022.09.006_bib0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cca.2013.05.022","article-title":"Circulating cell free DNA: preanalytical considerations","volume":"424","author":"El Messaoudi","year":"2013","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"41","key":"10.1016\/j.cancergen.2022.09.006_bib0036","doi-asserted-by":"crossref","first-page":"66595","DOI":"10.18632\/oncotarget.10704","article-title":"Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma","volume":"7","author":"Rachiglio","year":"2016","journal-title":"Oncotarget [Internet]"},{"issue":"2","key":"10.1016\/j.cancergen.2022.09.006_bib0037","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2018.4305","article-title":"Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer","volume":"5","author":"Aggarwal","year":"2019","journal-title":"JAMA Oncol"},{"issue":"23","key":"10.1016\/j.cancergen.2022.09.006_bib0038","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1158\/1078-0432.CCR-16-1231","article-title":"Detection of therapeutically targetable driver and resistance mutations in lung cancer patients by next-generation sequencing of cell-free circulating tumor DNA","volume":"22","author":"Thompson","year":"2016","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776222001211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776222001211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:25:12Z","timestamp":1778840712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776222001211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":38,"alternative-id":["S2210776222001211"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2022.09.006","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2022.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}